Contraindicated conditions that warrant caution in the treatment of Seleniso (Silvio)

Selinisol (Silvio) , as an innovative targeted drug, has been widely used to treat serious hematological tumors such as multiple myeloma (MM) and refractory or relapsed large B cell lymphoma (rrDLBCL). However, despite its remarkable efficacy, not every patient is suitable for treatment with selinexol (Silvio) . In order to ensure patient safety, the following contraindications must be noted:

For those patients who already have severe myelosuppression, selinesol (Silvio) is not an appropriate treatment option. Myelosuppression may manifest as symptoms such as a significant decrease in white blood cell count, anemia, or thrombocytopenia. In this case, the use of selinesol (Silvio) may further aggravate blood function abnormalities and even cause more complications.

Selinesol (Silvio) should also be avoided if patients have severe hepatic impairment. This is because the drug completes the metabolic process in the liver. Impaired liver function may affect the normal metabolism and excretion of the drug, leading to excessive accumulation of the drug in the body and increasing the risk of potential toxicity.

Seliniso (Silvio) should also be used with caution in patients with severe renal insufficiency. Since the drug is mainly excreted through the kidneys, a decline in renal function may block the excretion of the drug, causing it to remain in the body, thereby exacerbating the side effects of the drug.

If a patient has an allergic reaction, such as an allergic rash, hives, or difficulty breathing, to Selinisol (Sivio) or any of its ingredients, they should stop using the drug immediately. At the same time, it is not recommended for those patients who experience serious adverse reactions after using Celinexol (Silvio), such as arrhythmia or thromboembolism.

In particular, pregnant and breastfeeding women should avoid useSelinexol (Silvio) because this drug may cause potential harm to the fetus or infant. Patients should take effective contraceptive measures during treatment and for a period after treatment to prevent unwanted pregnancy.

In addition to the contraindications specifically listed above, caution should be exercised when using Selinisol (Silvio) in patients who have other serious medical conditions or who are receiving other treatments. This is because selinexol (Silvio) may interact with other medications, increasing the risk of adverse reactions.

Although selinesol (Silvio) has shown significant results in anti-tumor treatment, it is not suitable for all patients. When formulating a treatment plan, doctors should comprehensively evaluate the patient's specific condition to ensure that there are no contraindications mentioned above, so as to choose the safest and most effective treatment plan for the patient. At the same time, patients should maintain a high degree of alertness during treatment and promptly report any discomfort or abnormal reactions to the doctor.